Mark A Munger

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. pmc In vivo human time-exposure study of orally dosed commercial silver nanoparticles
    Mark A Munger
    Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA Electronic address
    Nanomedicine 10:1-9. 2014
  2. doi request reprint Community pharmacists' occupational satisfaction and stress: a profession in jeopardy?
    Mark A Munger
    College of Pharmacy, University of Utah, 2000 East, 30 South, Rm 105M, Salt Lake City, UT 84112 5820, USA
    J Am Pharm Assoc (2003) 53:282-96. 2013
  3. doi request reprint Safety of prescribing PDE-5 inhibitors via e-medicine vs traditional medicine
    Mark A Munger
    Department of Internal Medicine, Universityof Utah, Salt Lake City 84112 5820, USA
    Mayo Clin Proc 83:890-6. 2008
  4. pmc Medication nonadherence: an unrecognized cardiovascular risk factor
    Mark A Munger
    Departments of Pharmacotherapy and Internal Medicine, University of Utah, Salt Lake City, Utah, USA
    MedGenMed 9:58. 2007
  5. ncbi request reprint Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment
    Mark A Munger
    Department of Pharmacotherapy and Internal Medicine, University of Utah, Salt Lake City, Utah 84112, USA
    Pharmacotherapy 27:619-25. 2007
  6. ncbi request reprint Management of acute decompensated heart failure: treatment, controversy, and future directions
    Mark A Munger
    Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah 84112 5820, USA
    Pharmacotherapy 26:131S-138S. 2006
  7. ncbi request reprint Epidemiology and practice patterns of acute decompensated heart failure
    Mark A Munger
    Department of Pharmacy Practice and Internal Medicine, University of Utah, UTAH Affiliated Heart Failure Prevention and Treatment Program, 30 South, 2000 East, Room 258, Salt Lake City, UT 84112 5820, USA
    Am J Health Syst Pharm 60:S3-6. 2003
  8. doi request reprint Misoprostol effects on diclofenac-induced cardiorenal changes in salt-sensitive patients with hypertension: the MEDIC Study
    Mark A Munger
    Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah 84112 5820, USA
    Pharmacotherapy 28:834-42. 2008
  9. ncbi request reprint Aliskiren for renin inhibition: a new class of antihypertensives
    Benjamin W Van Tassell
    Experimental Cardiovascular Pharmacotherapy, Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT 84112, USA
    Ann Pharmacother 41:456-64. 2007
  10. ncbi request reprint New agents for managing hyponatremia in hospitalized patients
    Mark A Munger
    College of Pharmacy, University of Utah, 30 South 2000 East, Room 201, Salt Lake City, UT 84112 5820, USA
    Am J Health Syst Pharm 64:253-65. 2007

Detail Information

Publications21

  1. pmc In vivo human time-exposure study of orally dosed commercial silver nanoparticles
    Mark A Munger
    Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA Electronic address
    Nanomedicine 10:1-9. 2014
    ..Further study of increasing time exposure and dosing of silver nanoparticulate silver, and observation of additional organ systems are warranted to assert human toxicity thresholds...
  2. doi request reprint Community pharmacists' occupational satisfaction and stress: a profession in jeopardy?
    Mark A Munger
    College of Pharmacy, University of Utah, 2000 East, 30 South, Rm 105M, Salt Lake City, UT 84112 5820, USA
    J Am Pharm Assoc (2003) 53:282-96. 2013
    ..To quantify and model drivers of community pharmacists' self-reported levels of occupational satisfaction and stress and to identify key segments for possible intervention by the profession...
  3. doi request reprint Safety of prescribing PDE-5 inhibitors via e-medicine vs traditional medicine
    Mark A Munger
    Department of Internal Medicine, Universityof Utah, Salt Lake City 84112 5820, USA
    Mayo Clin Proc 83:890-6. 2008
    ..To determine the safety of a US-based, state-regulated Internet system vs a multispecialty primary care system for prescribing phosphodiesterase type 5 (PDE-5) inhibitors for erectile dysfunction...
  4. pmc Medication nonadherence: an unrecognized cardiovascular risk factor
    Mark A Munger
    Departments of Pharmacotherapy and Internal Medicine, University of Utah, Salt Lake City, Utah, USA
    MedGenMed 9:58. 2007
    ..Numerous strategies to improve medication adherence are available, from enhancing patient education to providing medication adherence information to the healthcare team and will be discussed in this article...
  5. ncbi request reprint Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment
    Mark A Munger
    Department of Pharmacotherapy and Internal Medicine, University of Utah, Salt Lake City, Utah 84112, USA
    Pharmacotherapy 27:619-25. 2007
    ....
  6. ncbi request reprint Management of acute decompensated heart failure: treatment, controversy, and future directions
    Mark A Munger
    Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah 84112 5820, USA
    Pharmacotherapy 26:131S-138S. 2006
    ..This article highlights our current understanding of acute decompensated heart failure, discusses the controversy surrounding currently available new vasoactive treatments, and details future potential therapies...
  7. ncbi request reprint Epidemiology and practice patterns of acute decompensated heart failure
    Mark A Munger
    Department of Pharmacy Practice and Internal Medicine, University of Utah, UTAH Affiliated Heart Failure Prevention and Treatment Program, 30 South, 2000 East, Room 258, Salt Lake City, UT 84112 5820, USA
    Am J Health Syst Pharm 60:S3-6. 2003
    ....
  8. doi request reprint Misoprostol effects on diclofenac-induced cardiorenal changes in salt-sensitive patients with hypertension: the MEDIC Study
    Mark A Munger
    Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah 84112 5820, USA
    Pharmacotherapy 28:834-42. 2008
    ..To determine whether coadministration of misoprostol with the nonsteroidal antiinflammatory drug diclofenac lessens the increase in blood pressure and improves the alterations in renal hemodynamics induced by diclofenac...
  9. ncbi request reprint Aliskiren for renin inhibition: a new class of antihypertensives
    Benjamin W Van Tassell
    Experimental Cardiovascular Pharmacotherapy, Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT 84112, USA
    Ann Pharmacother 41:456-64. 2007
    ..To review the safety, efficacy, pharmacology, pharmacokinetics, and drug interactions of aliskiren for the treatment of mild-to-moderate hypertension...
  10. ncbi request reprint New agents for managing hyponatremia in hospitalized patients
    Mark A Munger
    College of Pharmacy, University of Utah, 30 South 2000 East, Room 201, Salt Lake City, UT 84112 5820, USA
    Am J Health Syst Pharm 64:253-65. 2007
    ..An overview of hyponatremia is provided, including its pathophysiology, clinical manifestations, signs and symptoms, and treatment, particularly with arginine vasopressin (AVP)-receptor antagonists...
  11. doi request reprint Combination therapy with beta-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failure
    Benjamin W Van Tassell
    Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT 84112, USA
    Pharmacotherapy 28:1523-30. 2008
    ..Compartmentation of cyclic adenosine 3',5'-monophosphate signaling may prove critical in determining myocardial response to combination therapy...
  12. ncbi request reprint Faculty turnover within academic pharmacy departments
    Orly Carter
    Pharmacy Services, University of Utah Hospitals and Clinics, Salt Lake City, UT 84132 1915, USA
    Ann Pharmacother 37:197-201. 2003
    ..Previous investigations studied job satisfaction among faculty members, but have not evaluated faculty retention and turnover among academic pharmacy departments...
  13. doi request reprint Polypharmacy and combination therapy in the management of hypertension in elderly patients with co-morbid diabetes mellitus
    Mark A Munger
    College of Pharmacy, University of Utah, Salt Lake City, Utah 84112, USA
    Drugs Aging 27:871-83. 2010
    ..Rational combination therapy can maximize BP control along with glycaemic control and help maximize the benefits of polypharmacy on outcomes in elderly patients with hypertension and co-morbid diabetes...
  14. doi request reprint Assessment of time to follow-up visits in newly-treated hypertensive patients using an electronic medical record database
    Diana I Brixner
    University of Utah College of Pharmacy, Department of Pharmacotherapy, Salt Lake City, UT 84112, USA
    Curr Med Res Opin 26:1881-91. 2010
    ..Findings were compared to treatment guidelines which recommend monthly follow-up in treatment naive patients until blood pressure (BP) levels are controlled...
  15. ncbi request reprint Assessment of orally dosed commercial silver nanoparticles on human ex vivo platelet aggregation
    Kristi J Smock
    Department of Pathology and ARUP Laboratories Institute for Clinical and Experimental Pathology, Health Sciences, University of Utah, Salt Lake City, Utah, UT 84112, USA
    Nanotoxicology 8:328-33. 2014
    ..e., active and placebo solutions). Enhanced ex vivo platelet activation was not detectable at peak serum silver concentrations <10 µg/L. Further studies of colloidal silver nanoparticles on human platelet activities are warranted...
  16. ncbi request reprint Atherothrombosis: epidemiology, pathophysiology, and prevention
    Mark A Munger
    Department of Pharmacy Practice, College of Pharmacy, University of Utah, Salt Lake City, USA
    J Am Pharm Assoc (2003) 44:S5-12; quiz S12-3. 2004
    ....
  17. pmc Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: evidence of improved vascular alpha1-adrenoreceptor signal transduction
    Benjamin W Van Tassell
    Department of Pharmacotherapy, University of Utah, Salt Lake City, UT 84112, USA
    Am Heart J 156:315-21. 2008
    ..We examined alpha(1)-AR signal transduction by repeat phenylephrine (PE) infusions in patients with HF receiving chronic carvedilol therapy...
  18. doi request reprint High-impact articles related to the management of heart failure: 2008 update
    Cynthia A Jackevicius
    Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, California, USA
    Pharmacotherapy 29:82-120. 2009
    ..In addition, consensus documents formed by expert panels are reviewed. This compilation may serve as a teaching tool, reference resource, or update of the literature for pharmacy clinicians, physicians, and students...
  19. ncbi request reprint Chronically inhaled salmeterol improves pulmonary function in heart failure
    Tien M H Ng
    Department of Pharmacy Practice, University of Utah Health Sciences Center, Salt Lake City, UT, USA
    J Cardiovasc Pharmacol 40:140-5. 2002
    ..The plasma half-life of salmeterol may be prolonged in heart failure patients, thus leading to accumulation at steady-state...
  20. ncbi request reprint Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy
    Waymon Drummond
    Renaissance Research and Hypertension of Texas, Dallas, TX 75235 6209, USA
    J Clin Hypertens (Greenwich) 9:742-50. 2007
    ....
  21. ncbi request reprint High-impact articles related to the pharmacotherapeutic management of systolic heart failure
    Tien M H Ng
    School of Pharmacy, University of Southern California, Los Angeles, California, 90033, USA
    Pharmacotherapy 24:1594-633. 2004
    ..This compilation may serve as a teaching tool, reference resource, or update of the literature for pharmacy clinicians, physicians, and students...